Physician profile
Russell Anderson
NPI 1114939733
$553.33
in general payments reported to CMS, 2019-2025
9 companies · $139 in 2025
The $139 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.46 · 2020: $25.64 · 2022: $106 · 2023: $206 · 2024: $42.84 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $387.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $187.80 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Genentech, INC. | $139.48 | 2025 | |
| Janssen Pharmaceuticals, INC | $91.96 | 2022-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $42.84 | 2024 | Andexxa |
| Portola Pharmaceuticals, LLC | $32.14 | 2019-2020 | |
| Pfizer INC. | $16.49 | 2022 | |
| Abbott Laboratories | $15.66 | 2022 | |
| Btg International INC. | $13.48 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $13.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.